142 related articles for article (PubMed ID: 344223)
1. Adult mice as a model for early onset group B streptococcal disease.
Wennerstrom DE; Schutt RW
Infect Immun; 1978 Feb; 19(2):741-4. PubMed ID: 344223
[TBL] [Abstract][Full Text] [Related]
2. The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats.
Martin TR; Ruzinski JT; Rubens CE; Chi EY; Wilson CB
J Infect Dis; 1992 Feb; 165(2):306-14. PubMed ID: 1730897
[TBL] [Abstract][Full Text] [Related]
3. Group B streptococcal type Ia sepsis in mice after intranasal inoculation and the effect of infection on lungs.
Wennerstrom DE
Infect Immun; 1979 Oct; 26(1):287-93. PubMed ID: 387606
[TBL] [Abstract][Full Text] [Related]
4. Virulence of human and bovine isolates of group B streptococci (types Ia and III) in experimental pregnant mouse models.
Poutrel B; Dore J
Infect Immun; 1985 Jan; 47(1):94-7. PubMed ID: 3880731
[TBL] [Abstract][Full Text] [Related]
5. Experimental infection with group B streptococci in tissue cages implanted in rabbits.
Wagner M; Wagner B; Bergholm AM; Holm SE
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):242-55. PubMed ID: 6397945
[TBL] [Abstract][Full Text] [Related]
6. Cytokine response to group B streptococcus infection in mice.
Rosati E; Fettucciari K; Scaringi L; Cornacchione P; Sabatini R; Mezzasoma L; Rossi R; Marconi P
Scand J Immunol; 1998 Apr; 47(4):314-23. PubMed ID: 9600312
[TBL] [Abstract][Full Text] [Related]
7. Glutathione Synthesis Contributes to Virulence of
Walker EA; Port GC; Caparon MG; Janowiak BE
J Bacteriol; 2019 Oct; 201(20):. PubMed ID: 31331978
[No Abstract] [Full Text] [Related]
8. Lethal synergism induced in mice by influenza type A virus and type Ia group B streptococci.
Jones WT; Menna JH; Wennerstrom DE
Infect Immun; 1983 Aug; 41(2):618-23. PubMed ID: 6347892
[TBL] [Abstract][Full Text] [Related]
9. Group B streptococci. Role of capsular polysaccharide on virulence and induction of septic arthritis.
Tissi L; von Hunolstein C; Parisi L; Bistoni F; Orefici G
Adv Exp Med Biol; 1997; 418():817-8. PubMed ID: 9331777
[No Abstract] [Full Text] [Related]
10. Type III group B streptococcal infections in mice: bacteremia and meningitis following oral inoculation.
Lounsbery JL; Green LR; Furtado D
Can J Microbiol; 1981 Nov; 27(11):1150-5. PubMed ID: 7032679
[TBL] [Abstract][Full Text] [Related]
11. Experimental group B streptococcal infections in mice: hematogenous virulence and mucosal colonization.
Furtado D
Infect Immun; 1976 May; 13(5):1315-20. PubMed ID: 773831
[TBL] [Abstract][Full Text] [Related]
12. Streptococcus agalactiae infection in zebrafish larvae.
Kim BJ; Hancock BM; Del Cid N; Bermudez A; Traver D; Doran KS
Microb Pathog; 2015 Feb; 79():57-60. PubMed ID: 25617657
[TBL] [Abstract][Full Text] [Related]
13. Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.
Durham DL; Mattingly SJ; Doran TI; Milligan TW; Straus DC
Infect Immun; 1981 Nov; 34(2):448-54. PubMed ID: 7030959
[TBL] [Abstract][Full Text] [Related]
14. Group B streptococci: determinants of invasive neonatal infection.
Boyer KM
Mead Johnson Symp Perinat Dev Med; 1982; (21):47-51. PubMed ID: 6765459
[No Abstract] [Full Text] [Related]
15. Changing pattern of neonatal streptococcal septicemia.
Spigelblatt L; Saintonge J; Chicoine R; Laverdière M
Pediatr Infect Dis; 1985; 4(1):56-8. PubMed ID: 3881743
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae.
Poyart C; Pellegrini E; Gaillot O; Boumaila C; Baptista M; Trieu-Cuot P
Infect Immun; 2001 Aug; 69(8):5098-106. PubMed ID: 11447191
[TBL] [Abstract][Full Text] [Related]
17. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
Baker CJ; Edwards MS; Webb BJ; Kasper DL
J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
[TBL] [Abstract][Full Text] [Related]
18. Effects of route and time of administration of antiserum on protection of mice from lethal infection due to group B Streptococcus type III.
Stanton BF; Baltimore RS; Shedd DG
Infect Immun; 1981 Jan; 31(1):391-5. PubMed ID: 7011999
[TBL] [Abstract][Full Text] [Related]
19. Virulence of strains of new types and type candidates of group B streptococci (Streptococcus agalactiae). Comparative evaluation using mice and a chicken embryo model.
Wagner M; Kaatz M
Adv Exp Med Biol; 1997; 418():819-21. PubMed ID: 9331778
[No Abstract] [Full Text] [Related]
20. Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide.
VON Hunolstein C; Parisi L; Tissi L; Recchia S; Alfarone G; Nicolini L; Volpe C; Wagner B; Motlova J; Orefici G
J Med Microbiol; 1999 Nov; 48(11):983-990. PubMed ID: 10535641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
